Inhalation Sciences AB: Subscription price determined for warrants of series TO 1 where the subscription period begins on May 23, 2022.

The subscription price in Inhalation Sciences' warrant of series TO 1 has, in accordance with the applicable terms for the warrants, been set at SEK 10.00 per share. The subscription period begins on May 23, 2022 and runs until June 3, 2022. The holder warrants have the right to subscribe for one new share in Inhalation Science for each warrant at a subscription price of SEK 10.00 per share.

Please note that with the current share price, it is not financially advantageous to exercise the options.

Trading with warrants is ongoing up to and including June 1, 2022. Warrants of series TO 1 that have not been exercised for subscription of shares by June 3, 2022, or sold by June 1, 2022, expire without value.

The outcome of the exercise of warrants will be published via a press release in June 2022.

For more information about Inhalation Sciences, please contact:

Manoush Masarrat, CEO

E-mail: Manoush.masarrat@inhalation.se

Mobile: +46 (0)73 628 9153

About Inhalation Sciences Sweden AB (publ)

Inhalation Sciences Sweden AB (publ) develops and commercializes world-leading instruments and services for research into inhalation. The company’s patented lab instruments PreciseInhale® and DissolvIt® enable researchers in the pharma industry to make drug pipeline decisions at an early stage, saving time and resources for R&D departments, and enables researchers in academic institutions to define how aerosols and small particles impact our lungs, and so our health, when being inhaled.